HLA-G and neoplasm: One strategy successfully deployed by cancer cells for immune evasion is the impairment of the classical HLA class I and II antigens to hide infected cells from T cell recognition, while aberrant induction of HLA-G expression by cancer cells makes host anti-tumor immune system rather vulnerable (92).